Summit Research Cuts Price Target on Vipshop Holdings (VIPS) Following 2Q15 Results

Go back to Summit Research Cuts Price Target on Vipshop Holdings (VIPS) Following 2Q15 Results

Brean Capital Cuts Price Target on Vipshop Holdings (VIPS) Following 2Q15

August 12, 2015 7:22 AM EDT

Brean Capital maintained a Buy rating on Vipshop Holdings (NYSE: VIPS), and cut the price target to $25.00 (from $30.00), following the company's 2Q15 earnings results. VIPS reported 2Q15 net revenue of RMB 9.02bn, exceeding consensus estimates of RMB 8.96bn. EPS came in at $0.14, beating Street expectations of $0.12.... More

Notable 52-Week Highs and Lows 8/11: (NVAX) (LPCN) (ADBE) High; (VIPS) (RAX) (ONVO) Low

August 11, 2015 2:57 PM EDT

52-Week High:Novavax (Nasdaq: NVAX) $15.01. Novavax gaining Tuesday after it reported Q2 EPS of ($0.08), which was $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $14 million versus the consensus estimate of $9.9 million. The company also announced positive top-line data from a Phase 2 clinical trial of its RSV F-protein recombinant nanoparticle vaccine candidate (RSV F Vaccine) in older adults... More

Vipshop Holdings (VIPS) Tops Q2 EPS by 2c

August 10, 2015 4:05 PM EDT

Vipshop Holdings (NYSE: VIPS) reported Q2 EPS of $0.14, $0.02 better than the analyst estimate of $0.12. Revenue for the quarter came in at $1.5 million versus the consensus estimate of $1.45 million.

For earnings history and earnings-related data on Vipshop Holdings (VIPS) click here.

... More